U.S. Genomics names Canepa CEO

Dec. 16, 2005 — U.S. Genomics, a developer of single molecule analysis technologies for life science and biodefense applications, announced that John Canepa has been promoted to president, chief executive officer and a member of the board of directors.

Canepa originally joined U.S. Genomics as chief financial officer. During his tenure as CFO, Canepa saw the company through the development and launch of its Trilogy 2020 platform and Direct miRNA assays and through two phases of a multi-million-dollar biodefense contract with the U.S. Department of Homeland Security.

Prior to joining U.S. Genomics, Canepa served as vice president, finance & administration, and chief financial officer of Winphoria Networks Inc., a venture capital-backed telecommunications company.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.